Publications by authors named "Nagi Idris"

Claim this Profile
A
Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model.
Idil Mitsadali, Ben Grayson, Nagi F Idris, Linzi Watson, Matthew Burgess

J Psychopharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficits in social behavioral tests in a mouse model of alternating hemiplegia of childhood.
Greer S Kirshenbaum, Nagi F Idris, James Dachtler, John C Roder, Steven J Clapcote

J Neurogenet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
Samantha L McLean, Nagi F Idris, Ben Grayson, David F Gendle, Claire Mackie

J Psychopharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.
Charles H Large, Silvia Bison, Ilaria Sartori, Kevin D Read, Alessandro Gozzi, Nagi Idris

J Pharmacol Exp Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD168077, a D(4) receptor agonist, reverses object recognition deficits in rats: potential role for D(4) receptor mechanisms in improving cognitive dysfunction in schizophrenia.
Pooja Sood, Nagi F Idris, Susan Cole, Ben Grayson, Joanna C Neill

J Psychopharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
Samantha L McLean, Ben Grayson, Nagi F Idris, Anne S Lesage, Darrel J Pemberton

Eur Neuropsychopharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
Shikha Snigdha, Nagi Idris, Ben Grayson, Mohammed Shahid, Jo C Neill

Psychopharmacology (Berl)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
Samantha L McLean, Jo C Neill, Nagi F Idris, Hugh M Marston, Erik H F Wong

Behav Brain Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Joanna C Neill, Samuel Barnes, Samantha Cook, Ben Grayson, Nagi F Idris

Pharmacol Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.
Nagi Idris, Jo Neill, Ben Grayson, Benny Bang-Andersen, Louise M Witten

Psychopharmacology (Berl)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of two anticonvulsants, phenytoin and valproate to improve PCP and d-amphetamine induced deficits in a reversal learning task in the rat.
Nagi F Idris, Jo C Neill, Charles H Large

Front Behav Neurosci· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
Samantha L McLean, Nagi F Idris, Marie L Woolley, Joanna C Neill

Eur Neuropsychopharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis